Joint Stock Co Pharmstandard Public, 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 67,371 shares at $4.55 ($305K) on 2016-08-24, disclosed to the SEC on 2016-08-25.
Open-market purchase of $305k ARGS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.36 | 9,599 | $42K | 13.7% |
| 2 | $4.55 | 57,772 | $263K | 86.3% |
| Total | $4.52 avg | 67,371 | $305K | 100% |
| Filing → |
| ARGS | BUY | 2016-09-21 | $420K | — | Filing → |
| ARGS | BUY | 2016-09-20 | $501K | — | Filing → |
| PRTO | BUY | 2014-10-29 | $6.0M | — | Filing → |